Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386041777> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4386041777 endingPage "S124" @default.
- W4386041777 startingPage "S124" @default.
- W4386041777 abstract "BACKGROUND CONTEXT Lumbar discectomy is commonly performed in rheumatoid arthritis (RA) patients. Knowing that those with RA are at increased risk of adverse events after other procedures, their relative risk after lumbar discectomy was assessed. STUDY DESIGN/SETTING Retrospective cohort study. METHODS Lumbar discectomy patients were identified from the PearlDiver MSpine dataset. Those with RA were identified and matched 1:4 to those without RA based on patient age, sex, and Elixhauser Comorbidity Index (ECI) scores. The incidence of 90-day adverse events in the two groups was determined and compared by univariate and multivariate analyses. Lumbar discectomy patients with RA were then categorized based on prescribed medications: no biologics or disease-modifying antirheumatic drugs (DMARDs), DMARDs only, or biologics ± DMARDs. Multivariate logistic regression was performed to determine the odds of experiencing any adverse events (AAE) for those in the medication subgroups (relative to those without RA) in the 90 days postoperatively. RESULTS After matching, 2,149 lumbar discectomy patients with RA and 8,485 without RA were identified. RA patients had a greater incidence of AAE (32.0% versus 12.8%, p<0.0001). Controlling for patient age, sex, and ECI, those with RA were at significantly higher risk for any (odds ratio [OR] 3.30), severe (OR 2.78), and minor (OR 3.30) adverse events compared to those without (p<0.0001 for all). Stratifying by medication and relative to those without RA, RA patients on biologic ± DMARD therapy were at the highest risk for any adverse event following surgery (OR 5.69), followed by those on DMARDs alone (OR 3.87), and those not on biologic or DMARD therapy (OR 2.33) (p<0.0001 for all). No statistically significant difference in 5-year survival to subsequent lumbar surgery was found between patients with and without RA (p=0.1000). CONCLUSIONS Lumbar discectomy patients with RA were at significantly higher risk for 90-day adverse events following lumbar discectomy, with incrementally greater risk for those on increasingly immunosuppressive medications. There was no difference in 5-year survival to reoperation between patients with and without RA. RA patients should be counseled about the greater risk of postoperative adverse events when undergoing lumbar discectomy. The greater risks associated with increasingly immunosuppressive medications raise the question of holding such drugs perioperatively. FDA Device/Drug Status This abstract does not discuss or include any applicable devices or drugs. Lumbar discectomy is commonly performed in rheumatoid arthritis (RA) patients. Knowing that those with RA are at increased risk of adverse events after other procedures, their relative risk after lumbar discectomy was assessed. Retrospective cohort study. Lumbar discectomy patients were identified from the PearlDiver MSpine dataset. Those with RA were identified and matched 1:4 to those without RA based on patient age, sex, and Elixhauser Comorbidity Index (ECI) scores. The incidence of 90-day adverse events in the two groups was determined and compared by univariate and multivariate analyses. Lumbar discectomy patients with RA were then categorized based on prescribed medications: no biologics or disease-modifying antirheumatic drugs (DMARDs), DMARDs only, or biologics ± DMARDs. Multivariate logistic regression was performed to determine the odds of experiencing any adverse events (AAE) for those in the medication subgroups (relative to those without RA) in the 90 days postoperatively. After matching, 2,149 lumbar discectomy patients with RA and 8,485 without RA were identified. RA patients had a greater incidence of AAE (32.0% versus 12.8%, p<0.0001). Controlling for patient age, sex, and ECI, those with RA were at significantly higher risk for any (odds ratio [OR] 3.30), severe (OR 2.78), and minor (OR 3.30) adverse events compared to those without (p<0.0001 for all). Stratifying by medication and relative to those without RA, RA patients on biologic ± DMARD therapy were at the highest risk for any adverse event following surgery (OR 5.69), followed by those on DMARDs alone (OR 3.87), and those not on biologic or DMARD therapy (OR 2.33) (p<0.0001 for all). No statistically significant difference in 5-year survival to subsequent lumbar surgery was found between patients with and without RA (p=0.1000). Lumbar discectomy patients with RA were at significantly higher risk for 90-day adverse events following lumbar discectomy, with incrementally greater risk for those on increasingly immunosuppressive medications. There was no difference in 5-year survival to reoperation between patients with and without RA. RA patients should be counseled about the greater risk of postoperative adverse events when undergoing lumbar discectomy. The greater risks associated with increasingly immunosuppressive medications raise the question of holding such drugs perioperatively." @default.
- W4386041777 created "2023-08-22" @default.
- W4386041777 creator A5008240918 @default.
- W4386041777 creator A5040035762 @default.
- W4386041777 creator A5062454278 @default.
- W4386041777 creator A5068570473 @default.
- W4386041777 date "2023-09-01" @default.
- W4386041777 modified "2023-10-09" @default.
- W4386041777 title "P33. Rheumatoid arthritis patients are at increased risk for adverse events following lumbar discectomy" @default.
- W4386041777 doi "https://doi.org/10.1016/j.spinee.2023.06.258" @default.
- W4386041777 hasPublicationYear "2023" @default.
- W4386041777 type Work @default.
- W4386041777 citedByCount "0" @default.
- W4386041777 crossrefType "journal-article" @default.
- W4386041777 hasAuthorship W4386041777A5008240918 @default.
- W4386041777 hasAuthorship W4386041777A5040035762 @default.
- W4386041777 hasAuthorship W4386041777A5062454278 @default.
- W4386041777 hasAuthorship W4386041777A5068570473 @default.
- W4386041777 hasConcept C120665830 @default.
- W4386041777 hasConcept C121332964 @default.
- W4386041777 hasConcept C126322002 @default.
- W4386041777 hasConcept C141071460 @default.
- W4386041777 hasConcept C151730666 @default.
- W4386041777 hasConcept C156957248 @default.
- W4386041777 hasConcept C167135981 @default.
- W4386041777 hasConcept C197934379 @default.
- W4386041777 hasConcept C2777575956 @default.
- W4386041777 hasConcept C2779343474 @default.
- W4386041777 hasConcept C44249647 @default.
- W4386041777 hasConcept C44575665 @default.
- W4386041777 hasConcept C61511704 @default.
- W4386041777 hasConcept C71924100 @default.
- W4386041777 hasConcept C72563966 @default.
- W4386041777 hasConcept C82789193 @default.
- W4386041777 hasConcept C86803240 @default.
- W4386041777 hasConceptScore W4386041777C120665830 @default.
- W4386041777 hasConceptScore W4386041777C121332964 @default.
- W4386041777 hasConceptScore W4386041777C126322002 @default.
- W4386041777 hasConceptScore W4386041777C141071460 @default.
- W4386041777 hasConceptScore W4386041777C151730666 @default.
- W4386041777 hasConceptScore W4386041777C156957248 @default.
- W4386041777 hasConceptScore W4386041777C167135981 @default.
- W4386041777 hasConceptScore W4386041777C197934379 @default.
- W4386041777 hasConceptScore W4386041777C2777575956 @default.
- W4386041777 hasConceptScore W4386041777C2779343474 @default.
- W4386041777 hasConceptScore W4386041777C44249647 @default.
- W4386041777 hasConceptScore W4386041777C44575665 @default.
- W4386041777 hasConceptScore W4386041777C61511704 @default.
- W4386041777 hasConceptScore W4386041777C71924100 @default.
- W4386041777 hasConceptScore W4386041777C72563966 @default.
- W4386041777 hasConceptScore W4386041777C82789193 @default.
- W4386041777 hasConceptScore W4386041777C86803240 @default.
- W4386041777 hasIssue "9" @default.
- W4386041777 hasLocation W43860417771 @default.
- W4386041777 hasOpenAccess W4386041777 @default.
- W4386041777 hasPrimaryLocation W43860417771 @default.
- W4386041777 hasRelatedWork W2150503314 @default.
- W4386041777 hasRelatedWork W2384738060 @default.
- W4386041777 hasRelatedWork W2394928703 @default.
- W4386041777 hasRelatedWork W2416097977 @default.
- W4386041777 hasRelatedWork W2593221778 @default.
- W4386041777 hasRelatedWork W2976934717 @default.
- W4386041777 hasRelatedWork W2993678931 @default.
- W4386041777 hasRelatedWork W3045583548 @default.
- W4386041777 hasRelatedWork W812086887 @default.
- W4386041777 hasRelatedWork W2185550546 @default.
- W4386041777 hasVolume "23" @default.
- W4386041777 isParatext "false" @default.
- W4386041777 isRetracted "false" @default.
- W4386041777 workType "article" @default.